Gulf War Illness: Clinical Trials

13 trials for Gulf War Illness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 unknown, 2 recruiting, 2 terminated. 13 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Completed 5, Unknown 3, Recruiting 2, Terminated 2, Active not recruiting 1
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 11Completed 1

Follow Gulf War Illness: new trials by email Literature Review of Gulf War Illness trials Research Report on Gulf War Illness

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Resistant Potato Starch to Alleviate GWI
Resistant Potato Starch - Gulf War Illness
Phase 2RecruitingVA Office of Research and Development522025-02-032026-05-06
Ca-Mg Butyrate in Gulf War Illness
Cal-Mag Butyrate, Placebo - Gulf War Illness, Chronic Fatigue
Phase 2RecruitingVA Office of Research and Development1202024-01-152026-10-19
Confirmation of Diet as a Treatment for Gulf War Illness
Dietary Intervention - Gulf War Syndrome, Gulf War Illness
Phase 2 / Phase 3CompletedAmerican University1112023-03-012026-10-05
Study of Bacopa in Gulf War Illness Patients
BacoMind® (Bacopa monnieri standardized extract), Placebo - Gulf War Illness
Phase 2Active not recruitingNova Southeastern University1702022-12-012026-11-13
Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER)
Resveratrol - Gulf War Illness
Phase 2UnknownVISN 17 Center of Excellence682018-08-012018-09-11
Development of a Polyphenol-rich Dietary Preparation for Treating Veterans With Gulf War Illness
Concord grape juice, Placebo Beverage - Gulf War Illness
Phase 1 / Phase 2CompletedIcahn School of Medicine at Mount Sinai362016-08-012020-06-29
D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)
D-cycloserine, Placebo - Gulf War Illness
Phase 2CompletedBoston University Charles River Campus222015-10-012026-09-09
Research Examining Gulf War Illness in Our Nations Service Members
Duloxetine, Pregabalin, Placebo - Gulf War Illness
Phase 2TerminatedVA Office of Research and Development1122015-06-242021-03-12
Methylphenidate Plus GWI-Nutrient Formula as a Treatment for Patients With Gulf War Illness
Methyl-P plus GWI Nutrient Formula - Gulf War Illness
Phase 2UnknownK-PAX Pharmaceuticals, Inc.302015-01-012015-10-15
Probiotic (Visbiome) for Gulf War Illness
Placebo, Visbiome, VSL#3 - Gulf War Illness
Phase 2 / Phase 3UnknownAshok Tuteja602013-09-132017-12-13
Probiotic (VSL #3) for Gulf War Illness
VSL#3, Placebo - Gulf War Illness
Phase 2 / Phase 3TerminatedUniversity of Utah292013-09-012018-10-26
Trial of Naltrexone and Dextromethorphan for Gulf War Illness
naltrexone, Dextromethorphan - Gulf War Illness
Phase 2CompletedEast Carolina University602012-01-012016-03-03
Gulf War Illness: Evaluation of an Innovative Detoxification Program
plain crystalline niacin, exercise, sauna - Gulf War Illness
Phase 2CompletedUniversity at Albany322010-04-012020-04-13

Narrower conditions

Persian Gulf Syndrome (3)  ·  Irritable Bowel Syndrome (2)  ·  Cognition Disorders (1)  ·  Motor Activity (1)  ·  Neuroinflammatory Diseases (1)

Broader conditions

Occupational Diseases (3)  ·  War-Related Injuries (3)  ·  Wounds and Injuries (3)  ·  Colonic Diseases (2)  ·  Colonic Diseases, Functional (2)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Behavior (1)  ·  Inflammation (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Sugars (3)  ·  Cycloserine (1)  ·  Dextromethorphan (1)  ·  Diet Therapy (1)  ·  Duloxetine Hydrochloride (1)  ·  Exercise (1)  ·  Naltrexone (1)  ·  Pregabalin (1)  ·  Resveratrol (1)  ·  Steam Bath (1)

Sponsors

VA Office of Research and Development (3)  ·  American University (1)  ·  Ashok Tuteja (1)  ·  Boston University Charles River Campus (1)  ·  East Carolina University (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  K-PAX Pharmaceuticals, Inc. (1)  ·  Nova Southeastern University (1)  ·  University at Albany (1)  ·  University of Utah (1)  ·  VISN 17 Center of Excellence (1)

Countries

United States (13)

Top investigators

Amanpreet Cheema, PhD (1)  ·  Ashok Tuteja, MD, MPH (1)  ·  Brett Chaney, MD (1)  ·  Charles J Foulks, M.D. (1)  ·  David O Carpenter, MD (1)  ·  Dena Davidson, Ph.D. (1)  ·  Giulio Maria Pasinetti, MD, PhD (1)  ·  Jon D. Kaiser, MD (1)  ·  Kathleen F Holton, PhD, MPH (1)  ·  Mark Holodniy, MD (1)  ·  Nasia Safdar, MD PhD (1)  ·  Rosemary Toomey, Ph.D. (1)  ·  Saurabh Chatterjee, PhD (1)

Results publications

PMID 33499551

NIH funding

I01CX002372 (1)